Korden Walter

Person

Wiesbaden, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies useful in cancer diagnosis
- Patent number 11,919,951
- Issue date Mar 5, 2024
- Astellas Pharma Inc.
- Rita Mitnacht-Kraus
- G01 - MEASURING TESTING
Information Patent Grant
Antibodies specific for claudin 6 (CLDN6)
- Patent number 11,858,988
- Issue date Jan 2, 2024
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies for treatment of cancer expressing claudin 6
- Patent number 11,859,008
- Issue date Jan 2, 2024
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diagnosis and therapy of cancer involving cancer stem cells
- Patent number 11,795,218
- Issue date Oct 24, 2023
- BioNTech AG
- Ugur Sahin
- G01 - MEASURING TESTING
Information Patent Grant
Drug conjugates comprising antibodies against claudin 18.2
- Patent number 11,541,127
- Issue date Jan 3, 2023
- Astellas Pharma, Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for diagnosis and treatment of cancer
- Patent number 11,473,085
- Issue date Oct 18, 2022
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies useful in cancer diagnosis
- Patent number 11,279,757
- Issue date Mar 22, 2022
- Astellas Pharma Inc.
- Rita Mitnacht-Kraus
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies for treatment of cancer expressing claudin 6
- Patent number 10,919,974
- Issue date Feb 16, 2021
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer therapy using CLDN6 target-directed antibodies in vivo
- Patent number 10,844,133
- Issue date Nov 24, 2020
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies specific for claudin 6 (CLDN6)
- Patent number 10,745,477
- Issue date Aug 18, 2020
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diagnosis and therapy of cancer involving cancer stem cells
- Patent number 10,604,568
- Issue date Mar 31, 2020
- BioN Tech AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies for treatment of cancer expressing claudin 6
- Patent number 10,233,253
- Issue date Mar 19, 2019
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specific for claudin 6 (CLDN6)
- Patent number 9,932,401
- Issue date Apr 3, 2018
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer therapy using CLDN6 target-directed antibodies in vivo
- Patent number 9,902,778
- Issue date Feb 27, 2018
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for diagnosis and treatment of cancer
- Patent number 9,809,815
- Issue date Nov 7, 2017
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer therapy using CLDN6 target-directed antibodies in vivo
- Patent number 9,718,886
- Issue date Aug 1, 2017
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specific for claudin 6 (CLDN6)
- Patent number 9,487,584
- Issue date Nov 8, 2016
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies for treatment of cancer
- Patent number 9,321,842
- Issue date Apr 26, 2016
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6
- Publication number 20240101703
- Publication date Mar 28, 2024
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)
- Publication number 20240092896
- Publication date Mar 21, 2024
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO
- Publication number 20240084033
- Publication date Mar 14, 2024
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS
- Publication number 20240059772
- Publication date Feb 22, 2024
- BIONTECH AG
- Ugur Sahin
- G01 - MEASURING TESTING
Information Patent Application
DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2
- Publication number 20230270878
- Publication date Aug 31, 2023
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
- Publication number 20230193261
- Publication date Jun 22, 2023
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES USEFUL IN CANCER DIAGNOSIS
- Publication number 20220162302
- Publication date May 26, 2022
- Astellas Pharma Inc.
- Rita MITNACHT-KRAUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6
- Publication number 20210179730
- Publication date Jun 17, 2021
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO
- Publication number 20210079113
- Publication date Mar 18, 2021
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS
- Publication number 20200385460
- Publication date Dec 10, 2020
- BIONTECH AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)
- Publication number 20200339677
- Publication date Oct 29, 2020
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES USEFUL IN CANCER DIAGNOSIS
- Publication number 20200199221
- Publication date Jun 25, 2020
- Astellas Pharma Inc.
- Rita MITNACHT-KRAUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
- Publication number 20190169614
- Publication date Jun 6, 2019
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6
- Publication number 20190010244
- Publication date Jan 10, 2019
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)
- Publication number 20180162938
- Publication date Jun 14, 2018
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO
- Publication number 20180142033
- Publication date May 24, 2018
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2
- Publication number 20180117174
- Publication date May 3, 2018
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
- Publication number 20180119146
- Publication date May 3, 2018
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO
- Publication number 20160355604
- Publication date Dec 8, 2016
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6
- Publication number 20160264677
- Publication date Sep 15, 2016
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)
- Publication number 20160222125
- Publication date Aug 4, 2016
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS
- Publication number 20160159901
- Publication date Jun 9, 2016
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES FOR TREATMENT OF CANCER
- Publication number 20140127219
- Publication date May 8, 2014
- Johannes Gutenberg-Universitat Mainz
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO
- Publication number 20130183305
- Publication date Jul 18, 2013
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)
- Publication number 20120308478
- Publication date Dec 6, 2012
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
- Publication number 20110300144
- Publication date Dec 8, 2011
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Korden Walter

Person

Patents Grantslast 30 patents

Antibodies useful in cancer diagnosis

Antibodies specific for claudin 6 (CLDN6)

Antibodies for treatment of cancer expressing claudin 6

Diagnosis and therapy of cancer involving cancer stem cells

Drug conjugates comprising antibodies against claudin 18.2

Methods and compositions for diagnosis and treatment of cancer

Antibodies useful in cancer diagnosis

Antibodies for treatment of cancer expressing claudin 6

Cancer therapy using CLDN6 target-directed antibodies in vivo

Antibodies specific for claudin 6 (CLDN6)

Diagnosis and therapy of cancer involving cancer stem cells

Antibodies for treatment of cancer expressing claudin 6

Antibodies specific for claudin 6 (CLDN6)

Cancer therapy using CLDN6 target-directed antibodies in vivo

Methods and compositions for diagnosis and treatment of cancer

Cancer therapy using CLDN6 target-directed antibodies in vivo

Antibodies specific for claudin 6 (CLDN6)

Antibodies for treatment of cancer

Patents Applicationslast 30 patents

ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6

ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO

DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS

DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER

ANTIBODIES USEFUL IN CANCER DIAGNOSIS

ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6

CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO

DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS

ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

ANTIBODIES USEFUL IN CANCER DIAGNOSIS

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER

ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6

ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO

DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER

CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO

ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6

ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS

ANTIBODIES FOR TREATMENT OF CANCER

CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO

ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER